Skip to content

Q2 FY26 Earnings Results

Q2 FY26 earnings, Jul–Sep 2025: 6,052 Indian listed companies have reported; median profit growth is +2.2% on last year, and 114 of 245 companies with analyst estimates beat them. Quarter ended 30 Sep 2025.

Q1Q2Q3Q4
Reported
6,052
companies
Profit breadth
51% / 45%
grew / declined · 4,400 comparable
Median sales YoY
+8.9%
across all reporters
Median profit YoY
+2.2%
across all reporters
Beat / missed
114 / 107
of 245 covered
Strongest / weakest
Food Products +22.2%
Forest Materials −33.3%
median profit growth, 10+ reporters
LargestFastest profit growthFastest sales growthBiggest beatsBiggest misses
Clear filters 1–100 of 269
CompanyRevenue (₹ Cr)Profit (₹ Cr)Per share8Q profit
Symbol Sector Reported YoY QoQ Reported YoY EPS vs consensus Trend
SUNPHARMA Sun Pharmaceutical Industries LtdHealthcare14,478up+8.9%up+4.5%3,125up+2.9%13.00Beat +2.4% est. 12.70
DRREDDY Dr Reddys Laboratories LtdHealthcare8,828up+9.8%up+3.0%1,337down−0.4%16.14No estimate
AUROPHARMA Aurobindo Pharma LtdHealthcare8,286up+6.3%up+5.3%848up+3.8%14.61Miss −4.7% est. 15.33
CIPLA Cipla LtdHealthcare7,589up+7.6%up+9.1%1,353up+3.7%16.73No estimate
LUPIN Lupin LtdHealthcare7,048up+24.2%up+12.4%1,485up+72.9%32.36Beat +30.3% est. 24.83
ZYDUSLIFE Zydus Lifesciences LtdHealthcare6,123up+16.9%down−6.9%1,239up+34.7%12.51Miss −4.2% est. 13.06
GLENMARK Glenmark Pharmaceuticals LtdHealthcare6,047up+76.1%up+85.3%610up+72.3%21.63No estimate
BIOCON Biocon LtdHealthcare4,296up+19.7%up+9.0%133up+392.6%0.63Beat +21.1% est. 0.55
ALKEM Alkem Laboratories LtdHealthcare4,001up+17.2%up+18.7%779up+11.0%63.99Beat +9.5% est. 58.43
MANKIND Mankind Pharma LtdHealthcare3,697up+20.8%up+3.6%520down−21.1%12.39No estimate
TORNTPHARM Torrent Pharmaceuticals LtdHealthcare3,302up+14.3%up+3.9%591up+30.5%17.46No estimate
DIVISLAB Divis Laboratories LtdHealthcare2,715up+16.1%up+12.7%689up+35.1%25.95Beat +6.4% est. 24.41
IPCALAB Ipca Laboratories LtdHealthcare2,556up+8.5%up+10.7%281up+14.2%11.14No estimate
EMCURE Emcure Pharmaceuticals LtdHealthcare2,270up+13.4%up+8.0%251up+24.3%12.84Beat +7.1% est. 12.00
PPLPHARMA Piramal Pharma LtdHealthcare2,044down−8.8%up+5.7%−99down−530.4%−0.75Miss −120.6% est. −0.34
JUBLPHARMA Jubilant Pharmova LtdHealthcare1,966up+12.2%up+3.4%120up+17.6%7.55No estimate
APLLTD Alembic Pharmaceuticals LtdHealthcare1,910up+15.9%up+11.6%184up+20.3%9.40Beat +3.7% est. 9.07
ABBOTINDIA Abbott India LtdHealthcare1,757up+7.6%up+1.1%415up+15.6%195.43No estimate
LAURUSLABS Laurus Labs LtdHealthcare1,653up+35.0%up+5.3%194up+870.0%3.61Beat +45.3% est. 2.49
GLAND Gland Pharma LtdHealthcare1,487up+5.8%down−1.3%184up+12.2%11.15Miss −18.2% est. 13.62
NATCOPHARM Natco Pharma LtdHealthcare1,363down−0.6%up+2.6%518down−23.4%26.42No estimate
AJANTPHARM Ajanta Pharma LtdHealthcare1,354up+14.1%up+3.9%260up+20.4%20.83No estimate
GRANULES Granules India LtdHealthcare1,297up+34.1%up+7.2%131up+35.1%5.38Beat +7.6% est. 5.00
STAR Strides Pharma Science LtdHealthcare1,221up+4.6%up+9.0%132up+83.3%13.84No estimate
JBCHEPHARM J B Chemicals & Pharmaceuticals LtdHealthcare1,085up+8.4%down−0.8%208up+18.9%13.27No estimate
AKUMS Akums Drugs & Pharmaceuticals LtdHealthcare1,018down−1.5%down−0.6%43down−35.8%2.59No estimate
GLAXO Glaxosmithkline Pharmaceuticals LtdHealthcare980down−3.1%up+21.7%257up+2.0%15.20No estimate
SYNGENE Syngene International LtdHealthcare911up+2.2%up+4.1%67down−36.8%1.67No estimate
VIYASH Viyash Scientific LtdHealthcare850up+130.4%up+7.3%73up+1,116.7%2.18No estimate
INDGN Indegene LtdHealthcare804up+17.0%up+5.7%102up+10.9%4.25No estimate
ERIS ERIS Lifesciences LtdHealthcare792up+6.9%up+2.5%134up+39.6%8.82No estimate
WOCKPHARMA Wockhardt LtdHealthcare782down−3.3%up+6.0%82n/a4.80No estimate
MARKSANS Marksans Pharma LtdHealthcare720up+12.1%up+16.1%99up+1.0%2.17No estimate
AARTIDRUGS Aarti Drugs LtdHealthcare653up+9.2%up+10.5%45up+28.6%4.96No estimate
DCAL Dishman Carbogen Amcis LtdHealthcare653down−17.2%down−7.8%65up+97.0%4.16No estimate
PFIZER Pfizer LtdHealthcare642up+9.0%up+6.5%189up+19.6%41.32No estimate
ALIVUS Alivus Life Sciences LtdHealthcare588up+16.0%down−2.3%130up+36.8%10.60Beat +12.8% est. 9.40
UNICHEMLAB Unichem Laboratories LtdHealthcare579up+14.2%up+9.9%−12down−148.0%−1.69No estimate
IOLCP IOL Chemicals & Pharmaceuticals LtdHealthcare568up+8.0%up+2.9%30up+57.9%1.02No estimate
ASTRAZEN Astrazeneca Pharma India LtdHealthcare559up+37.0%up+6.3%54up+42.1%21.69No estimate
COHANCE Cohance Lifesciences LtdHealthcare556down−7.9%up+1.3%66down−52.2%1.94Beat +29.3% est. 1.50
ANTHEM Anthem Biosciences LtdHealthcare550up+4.8%up+1.9%173up+6.8%3.09No estimate
SAILIFE Sai Life Sciences LtdHealthcare537up+35.6%up+8.3%84up+100.0%4.00Beat +43.2% est. 2.80
CAPLIPOINT Caplin Point Laboratories LtdHealthcare534up+10.6%up+4.7%160up+22.1%20.32No estimate
NEULANDLAB Neuland Laboratories LtdHealthcare514up+65.3%up+75.4%97up+193.9%75.49Beat +37.5% est. 54.92
Brabourne Enterprises Ltd(merged) Healthcare489up+89.5%down−3.6%64n/a2.25No estimate
INDOCO Indoco Remedies LtdHealthcare485up+12.0%up+10.2%−9n/a−0.86Miss −11.1% est. −0.90
SANOFI Sanofi India LtdHealthcare475down−9.4%up+17.0%76down−7.3%33.04No estimate
FDC FDC LtdHealthcare473down−8.0%down−27.0%28down−61.1%1.74No estimate
POLYMED Poly Medicure LtdHealthcare444up+5.7%up+10.2%92up+5.7%9.06No estimate
AARTIPHARM Aarti Pharmalabs LtdHealthcare418down−8.7%up+8.3%28down−49.1%3.08No estimate
MOREPENLAB Morepen Laboratories LtdHealthcare412down−5.9%down−3.1%41up+17.1%0.75No estimate
RUBICON Rubicon Research LtdHealthcare412up+39.2%up+17.0%54up+58.8%3.49No estimate
REMUS Remus Pharmaceuticals LtdHealthcare400up+46.5%n/a22up+15.8%14.85No estimate
INNOVACAP Innova Captab LtdHealthcare380up+19.5%up+8.0%30down−14.3%5.18No estimate
ONESOURCE OneSource Specialty Pharma LtdHealthcare376up+12.6%up+15.0%10n/a0.92No estimate
SHILPAMED Shilpa Medicare LtdHealthcare370up+7.6%up+15.3%44up+144.4%2.25No estimate
CORONA Corona Remedies LtdHealthcare361up+15.0%up+4.0%52up+20.9%8.53No estimate
PGHL Procter & Gamble Health LtdHealthcare325up+3.8%down−4.1%89up+8.5%53.34No estimate
HIKAL Hikal LtdHealthcare319down−29.7%down−16.3%−35down−290.7%−2.83No estimate
SOLARA Solara Active Pharma Sciences LtdHealthcare314down−9.5%down−1.6%−10down−225.0%−2.79No estimate
ACUTAAS Acutaas Chemicals LtdHealthcare306up+23.9%up+47.8%72up+89.5%8.82No estimate
CONCORDBIO Concord Biotech LtdHealthcare247down−20.3%up+21.1%63down−36.4%6.01No estimate
BLISSGVS Bliss GVS Pharma LtdHealthcare244up+11.9%up+17.9%29up+11.5%2.58No estimate
SMSPHARMA SMS Pharmaceuticals LtdHealthcare242up+22.8%up+23.5%25up+78.6%2.70No estimate
SANOFICONR Sanofi Consumer Healthcare India LtdHealthcare234up+46.3%up+5.9%63up+40.0%27.31No estimate
GUFICBIO Gufic BioSciences LtdHealthcare230up+12.7%up+1.3%15down−31.8%1.49No estimate
WINDLAS Windlas Biotech LtdHealthcare222up+18.7%up+5.7%18up+12.5%8.45No estimate
SUPRIYA Supriya Lifescience LtdHealthcare200up+20.5%up+37.9%50up+8.7%6.27No estimate
ORCHPHARMA Orchid Pharma LtdHealthcare194down−13.1%down−26.5%−6down−121.0%−1.13No estimate
VENUSREM Venus Remedies LtdHealthcare193up+13.5%up+40.9%20up+400.0%15.06No estimate
JSLL Jeena Sikho Lifecare LtdHealthcare190up+66.5%up+9.1%59up+117.7%4.73No estimate
ANUHPHR Anuh Pharma LtdHealthcare186up+12.0%0.0%8down−46.7%0.76No estimate
ADVENZYMES Advanced Enzyme Technologies LtdHealthcare185up+26.7%down−0.5%45up+36.4%3.87No estimate
RPGLIFE RPG Life Sciences LtdHealthcare182up+5.8%up+7.7%37up+825.0%22.28No estimate
BI Bilcare LtdHealthcare178down−11.9%down−4.3%−23n/a−5.25No estimate
Emergy Phaarma Ltd Healthcare171up+2.0%up+48.7%21down−18.6%20.14No estimate
BLUEJET Blue Jet Healthcare LtdHealthcare165down−20.7%down−53.5%52down−10.3%3.01Miss −14.0% est. 3.50
LINCOLN Lincoln Pharmaceuticals LtdHealthcare163up+1.2%up+5.8%20down−23.1%9.98No estimate
SUDEEPPHRM Sudeep Pharma LtdHealthcare163up+9.4%up+30.4%47down−4.1%4.71No estimate
SENORES Senores Pharmaceuticals LtdHealthcare162up+60.4%up+17.4%30up+130.8%7.03No estimate
WANBURY Wanbury LtdHealthcare160down−0.7%down−1.9%15up+89.3%4.35No estimate
INDSWFTLAB Ind-Swift Laboratories LtdHealthcare153up+1,175.0%0.0%8n/a0.98No estimate
BAJAJHCARE Bajaj Healthcare LtdHealthcare148up+11.3%down−0.7%11up+22.2%3.52No estimate
OSELDEVICE OSEL Devices LtdHealthcare147up+69.0%n/a15up+87.5%8.58No estimate
FREDUN Fredun Pharmaceuticals LtdHealthcare145up+35.5%up+20.8%10up+150.0%6.85No estimate
PANACEABIO Panacea Biotec LtdHealthcare141down−4.2%down−15.3%−14down−397.5%−2.27No estimate
Oriental Remedies & Herbals Ltd Healthcare138up+64.3%n/a24up+380.0%13.78No estimate
FERMENTA Fermenta Biotech LtdHealthcare130up+37.0%down−4.4%18up+62.1%6.14No estimate
ZOTA Zota Health Care LtdHealthcare129up+92.5%up+24.0%−16n/a−5.20No estimate
FABTECH Fabtech Technologies LtdHealthcare121up+106.8%up+78.6%28up+449.0%8.68No estimate
SYNCOMF Syncom Formulations (India) LtdHealthcare121up+19.8%up+3.4%17up+54.5%0.18No estimate
KOPRAN Kopran LtdHealthcare118down−22.2%down−12.8%−10down−234.4%−2.06No estimate
AMRUTANJAN Amrutanjan Health Care LtdHealthcare118up+7.1%up+25.1%14up+18.3%4.83No estimate
NGLFINE NGL Fine Chem LtdHealthcare117up+28.6%up+15.8%8down−20.0%12.79No estimate
KPL Kwality Pharmaceuticals LtdHealthcare111up+23.3%0.0%14up+75.0%13.61No estimate
SIGACHI Sigachi Industries LtdHealthcare110down−11.5%down−13.9%11down−49.9%0.28No estimate
RUBRAMEDICAMENTSLTD Centuple Global LtdHealthcare109up+2,17,080.0%up+827.3%1n/a2.41No estimate
SYSCHEMINDIALTD Syschem (India) LtdHealthcare104up+118.0%down−5.2%2n/a0.44No estimate
BETA Beta Drugs LtdHealthcare103n/aup+3.0%12n/a12.11No estimate

About Q2 FY26 earnings data

When are Q2 FY26 results announced?
Q2 FY26 covers the Jul–Sep 2025 quarter. Indian listed companies have up to 45 days after a quarter closes to file their results — 60 days for the January–March quarter — so results arrive in a wave over the weeks that follow rather than all at once. A quarter that has only just ended will look sparse and fill in.
Why do some Q2 FY26 growth figures show "n/a" instead of a percentage?
Growth is left blank whenever the comparison period was not profitable. A percentage change measured from a loss is arithmetic without meaning — a swing from a ₹10 crore loss to a ₹10 crore profit is not "200% growth", and publishing it as such would flatter the company. The reported figures for both periods are still shown, so the change is there to read directly.
Does the beat/miss verdict cover every company?
No, and the denominator matters. An analyst consensus existed for 245 of the 6,052 companies that reported Q2 FY26 — 4.0%. Beat, missed and in-line describe only those. Every other company is marked "no estimate" rather than being counted as in line, because nobody forecast it. Revenue and profit growth, by contrast, cover every company in the table.
What counts as an in-line result rather than a beat or a miss?
Reported earnings per share within ±2% of the consensus estimate. The band is set there because a tighter one classifies rounding as news, and a wider one swallows surprises that genuinely moved a stock.
Are the figures consolidated or standalone?
Consolidated where a company reports on that basis, standalone otherwise, with all money in ₹ crore. Figures are as filed by the company with the exchanges (NSE/BSE); they are not restated or adjusted.
What does the 8-quarter trend line show?
Quarterly net profit for the last eight quarters, oldest on the left, always ending on the quarter shown in the row. Two years covers both the seasonal shape of the business and its direction. The line breaks where a quarter is missing rather than drawing across the gap, so a break is a real absence of data and not a reported collapse.
How do I find only the companies that beat estimates in Q2 FY26?
Use the Result filter above the table and choose Beat, or sort by EPS surprise to rank every covered company by how far it landed from consensus. Both are reflected in the page URL, so a filtered view can be bookmarked or shared.

Figures are as reported by companies in their quarterly filings to the exchanges (NSE/BSE), in ₹ crore. Consolidated results are shown where a company reports them, otherwise standalone. Year-on-year and quarter-on-quarter growth is omitted where the comparison period was loss-making, since a percentage change from a negative base is not meaningful. Analyst consensus is an estimate, not a forecast of outcome.